Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Optimization of prostate cancer diagnosis by increasing the number of core biopsies based on gland volume.

Werahera PN, Sullivan K, La Rosa FG, Kim FJ, Lucia MS, O'Donnell C, Sidhu RS, Sullivan HT, Schulte B, Crawford ED.

Int J Clin Exp Pathol. 2012;5(9):892-9. Epub 2012 Oct 20.

2.

Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection.

Somford DM, Vreuls W, Jansen TS, van Basten JP, Vergunst H.

World J Urol. 2014 Apr;32(2):461-7. doi: 10.1007/s00345-013-1130-3. Epub 2013 Jul 20.

PMID:
23873356
3.

Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.

Tonttila PP, Lantto J, Pääkkö E, Piippo U, Kauppila S, Lammentausta E, Ohtonen P, Vaarala MH.

Eur Urol. 2016 Mar;69(3):419-25. doi: 10.1016/j.eururo.2015.05.024. Epub 2015 May 29.

PMID:
26033153
4.

Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.

Arsov C, Rabenalt R, Blondin D, Quentin M, Hiester A, Godehardt E, Gabbert HE, Becker N, Antoch G, Albers P, Schimmöller L.

Eur Urol. 2015 Oct;68(4):713-20. doi: 10.1016/j.eururo.2015.06.008. Epub 2015 Jun 23.

PMID:
26116294
6.

Detection rate of anterior prostate cancer in 226 patients submitted to initial and repeat transperineal biopsy.

Pepe P, Dibenedetto G, Pennisi M, Fraggetta F, Colecchia M, Aragona F.

Urol Int. 2014;93(2):189-92. doi: 10.1159/000358494. Epub 2014 Apr 26.

PMID:
24776888
8.

Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care.

Ukimura O, Coleman JA, de la Taille A, Emberton M, Epstein JI, Freedland SJ, Giannarini G, Kibel AS, Montironi R, Ploussard G, Roobol MJ, Scattoni V, Jones JS.

Eur Urol. 2013 Feb;63(2):214-30. doi: 10.1016/j.eururo.2012.09.033. Epub 2012 Sep 25. Review.

PMID:
23021971
9.

Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.

Eskicorapci SY, Guliyev F, Akdogan B, Dogan HS, Ergen A, Ozen H.

J Urol. 2005 May;173(5):1536-40.

PMID:
15821481
10.

Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.

Guazzoni G, Nava L, Lazzeri M, Scattoni V, Lughezzani G, Maccagnano C, Dorigatti F, Ceriotti F, Pontillo M, Bini V, Freschi M, Montorsi F, Rigatti P.

Eur Urol. 2011 Aug;60(2):214-22. doi: 10.1016/j.eururo.2011.03.052. Epub 2011 Apr 5.

PMID:
21482022
11.

The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL.

Ito K, Ohi M, Yamamoto T, Miyamoto S, Kurokawa K, Fukabori Y, Suzuki K, Yamanaka H.

Cancer. 2002 Nov 15;95(10):2112-9.

12.

Prostate cancer detection rates in different biopsy schemes. Which cores for which patients?

Cormio L, Scattoni V, Lorusso F, Perrone A, Di Fino G, Selvaggio O, Sanguedolce F, Bufo P, Montorsi F, Carrieri G.

World J Urol. 2014 Apr;32(2):341-6. doi: 10.1007/s00345-012-0989-8. Epub 2012 Nov 25.

PMID:
23184141
13.

[The role of prostate volume in ultrasound guided transrectal prostate biopsy: is it as important as a marker as PSA?].

Rodríguez-Patrón Rodríguez R, Mayayo Dehesa T, Burgos Revilla FJ, Alonso González M, Lennie Zucharino A, García González R.

Arch Esp Urol. 2005 Nov;58(9):903-13. Spanish.

PMID:
16430038
14.

Length of prostate biopsy cores: does it impact cancer detection?

Fiset PO, Aprikian A, Brimo F.

Can J Urol. 2013 Aug;20(4):6848-53.

PMID:
23930611
15.

Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?

Djavan B, Zlotta AR, Remzi M, Ghawidel K, Bursa B, Hruby S, Wolfram R, Schulman CC, Marberger M.

Urology. 1999 Nov;54(5):846-52.

PMID:
10565745
16.

The implication of initial 24-core transrectal prostate biopsy protocol on the detection of significant prostate cancer and high grade prostatic intraepithelial neoplasia.

Nomikos M, Karyotis I, Phillipou P, Constadinides C, Delakas D.

Int Braz J Urol. 2011 Jan-Feb;37(1):87-93; discussion 93.

17.

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1).

Chen R, Zhou LQ, Cai XB, Xie LP, Huang YR, He DL, Gao X, Xu CL, Ding Q, Wei Q, Yin CJ, Ren SC, Wang FB, Tian Y, Sun ZQ, Fu Q, Ma LL, Zheng JH, Ye ZQ, Ye DW, Xu DF, Hou JQ, Xu KX, Yuan JL, Gao X, Liu CX, Pan TJ, Sun YH; Chinese Prostate Cancer Consortium.

Asian J Androl. 2015 Nov-Dec;17(6):1017-21. doi: 10.4103/1008-682X.150846.

18.

Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.

Pokorny MR, de Rooij M, Duncan E, Schröder FH, Parkinson R, Barentsz JO, Thompson LC.

Eur Urol. 2014 Jul;66(1):22-9. doi: 10.1016/j.eururo.2014.03.002. Epub 2014 Mar 14.

PMID:
24666839
19.

A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.

Parekh DJ, Punnen S, Sjoberg DD, Asroff SW, Bailen JL, Cochran JS, Concepcion R, David RD, Deck KB, Dumbadze I, Gambla M, Grable MS, Henderson RJ, Karsh L, Krisch EB, Langford TD, Lin DW, McGee SM, Munoz JJ, Pieczonka CM, Rieger-Christ K, Saltzstein DR, Scott JW, Shore ND, Sieber PR, Waldmann TM, Wolk FN, Zappala SM.

Eur Urol. 2015 Sep;68(3):464-70. doi: 10.1016/j.eururo.2014.10.021. Epub 2014 Oct 27.

PMID:
25454615
20.

Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol.

Durkan GC, Sheikh N, Johnson P, Hildreth AJ, Greene DR.

BJU Int. 2002 Jan;89(1):33-9.

Supplemental Content

Support Center